This fellowship will involve the study of the human eye to find out about the health of the brain’s small blood vessels and nerve connections in people who have recently had a stroke.
People who have survived a previous stroke or transient ischaemic attack (TIA) are at particularly high risk of subsequent, ‘recurrent’ stroke with 30% having another stroke in the following five years. High blood pressure is the most important reversible risk factor for having a recurrent stroke. The aim of this study is to develop and test a self-monitoring system of high blood pressure, tailored to the needs of stroke and TIA survivors, which will include self-adjustment of medication where possible in consultation with a GP.
Watch the highlights summary video from the ISC Programme Committee, and find out about the result of the international HeadPoST trial, and take-homes from our International Development Officer, Sarah Belson.
Inflammation following stroke is highly damaging to brain cells. Can stem cells be used to reduce the damage of inflammation after stroke and promote brain repair?
There is evidence that during the coronavirus pandemic fewer people have been recorded to have transient ischaemic attack (TIA) or stroke. That’s why the Stroke Association is urging people to continue to act fast and call 999 if they experience signs of stroke.
We are funding the KeMIST (Kent Medicine Support in Stroke and TIA) trial, which will use the views of stroke and Transient Ischaemic Attack (TIA) survivors to design a life-long medicines support service which will be provided by pharmacists. The KeMIST trial researchers are holding an open event to support the trial between 2pm and 4pm on Friday 25 November 2016. The event is being held at the Universities at Medway Campus in Gillingham, Kent. Find out more.
This research aims to improve outcomes for Intracerebral Haemorrhage (ICH) patients by developing new emergency treatments to reduce swelling in the brain after ICH, and improving the care that patients receive.
PRESTIGE-AF is a new multi-million Euro initiative funded by the European Commission has been set up to help prevent stroke in patients with existing conditions.